Komori
Financial results presentation9218Mental Health Technologies Co.,Ltd.Information and Communications, Services and Others

Financial Results Presentation for the Third Quarter of the Fiscal Year Ending December 2026

In the third quarter of the fiscal year ending December 2026, revenue increased 38.5% year on year and operating profit increased 10.7%. The MHS business exceeded plan and drove company-wide profit higher, while the MWS business fell short of plan in both revenue and profit and is transitioning to profitability-focused structural reforms.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
38.5
Year-on-year change in net sales (%)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationQ3 FY20266 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales6,478 Millions of yen+38.5%
Operating profit480 Millions of yen+10.7%
Ordinary income445 Millions of yen+10.7%
Net income256 Millions of yen+4.6%
Operating profit margin7.4
Full-year earnings forecast
Net Sales
9,252 Millions of yen
Operating profit
700 Millions of yen
Adjusted operating profit
878 Millions of yen
Ordinary income
528 Millions of yen
Profit attributable to owners of parent for the quarter
286 Millions of yen
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales70.0%
Operating profit68.6%
Adjusted operating profit69.8%
Ordinary income84.2%
Profit attributable to owners of parent for the quarter89.6%
Segment revenue
MHS business75.1%
MWS Business65.2%
Other Businesses60.2%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Consolidated operating profit exceeded plan. Company-wide revenue and MWS business revenue and profit fell short of plan.
New initiatives
  • In the MWS business, organize low-margin projects and shift sales efforts toward high-LTV, high-margin projects.
  • In the MWS business, promote strict cost control, eliminate unprofitable projects and improve the turnover rate.
  • Revamp the upselling structure for ENT customers in the MHS business.
  • Improve the efficiency of customer support using AI.
  • Strengthen collaboration between the occupational physician cloud platform and IC Co.'s return-to-work business.
Key KPIsA metric the company considers important as a management benchmark.
  • MRR（ENT）173 Millions of yen
    Year on year against the same period last year+31.1%
  • MRR（SMB）88 Millions of yen
    Year on year against the same period last year+10.0%
  • NRR119.2 %
    Year on year against the same period last year+13.3%
  • Number of ENT contract groups264 Group
    Year on year against the same period last year+23.4%
  • Number of SMB contracted companies2,178 companies
    Year on year against the same period last year+9.2%
  • Average monthly ENT churn rate0.1 %
  • Average monthly SMB churn rate0.4 %
    Year on year against the same period last year±0%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
  • ENT contract unit price¥685 thousand
    Year on year against the same period last year+5.9%
  • SMB contract unit price¥47 thousand
    Year on year against the same period last year+2.2%
  • Number of ENT contract groups264 Group
    Year on year against the same period last year+23.4%
  • Number of SMB contracted companies2,178 companies
    Year on year against the same period last year+9.2%
Segment results
  • MHS business
    Net Sales3,427 Millions of yen
    Revenue_yoy_pct53.5
    Profit1,031 Millions of yen
    Profit_yoy_pct58.4
  • MWS Business
    Net Sales2,978 Millions of yen
    Revenue_yoy_pct26.7
    Profit193 Millions of yen
    Profit_yoy_pct-1.2
  • Other Businesses
    Net Sales71 Millions of yen
    Revenue_yoy_pct-24.4
    Profit-9 Millions of yen
Number of employees
Number of Employees1,662 People
Record dateEnd of September 2026
Hiring planHiring to continue in the MHS business, MWS business and Corporate division.
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredQ3 FY2026
Net Sales6,478 Millions of yen (YoY +38.5%)
Operating profit480 Millions of yen (YoY +10.7%)
Ordinary income445 Millions of yen (YoY +10.7%)
Net income256 Millions of yen (YoY +4.6%)
Operating profit margin7.4
Full-year earnings forecastNet Sales 9,252 Millions of yen / Operating profit 700 Millions of yen / Adjusted operating profit 878 Millions of yen / Ordinary income 528 Millions of yen / Profit attributable to owners of parent for the quarter 286 Millions of yen
Progress against full-year forecastNet Sales 70.0% / Operating profit 68.6% / Adjusted operating profit 69.8% / Ordinary income 84.2% / Profit attributable to owners of parent for the quarter 89.6% / Segment revenue MHS business 75.1% / MWS Business 65.2% / Other Businesses 60.2%
Self-assessment against the planConsolidated operating profit exceeded plan. Company-wide revenue and MWS business revenue and profit fell short of plan.
Segment resultsSegment MHS business / Net Sales 3,427 Millions of yen / Revenue_yoy_pct 53.5 / Profit 1,031 Millions of yen / Profit_yoy_pct 58.4, Segment MWS Business / Net Sales 2,978 Millions of yen / Revenue_yoy_pct 26.7 / Profit 193 Millions of yen / Profit_yoy_pct -1.2, Segment Other Businesses / Net Sales 71 Millions of yen / Revenue_yoy_pct -24.4 / Profit -9 Millions of yen / Profit_yoy_pct Not disclosed
Key KPIsIndicator name MRR（ENT） / Value 173 Millions of yen / Year on year against the same period last year 31.1 Millions of yen, Indicator name MRR（SMB） / Value 88 Millions of yen / Year on year against the same period last year 10 Millions of yen, Indicator name NRR / Value 119.2 % / Year on year against the same period last year 13.3 %, Indicator name Number of ENT contract groups / Value 264 Group / Year on year against the same period last year 23.4 Group, Indicator name Number of SMB contracted companies / Value 2,178 companies / Year on year against the same period last year 9.2 companies, Indicator name Average monthly ENT churn rate / Value 0.1 % / Year on year against the same period last year Not disclosed, Indicator name Average monthly SMB churn rate / Value 0.4 % / Year on year against the same period last year ±0%
Unit price and quantity metricsIndicator name ENT contract unit price / Value ¥685 thousand / Year on year against the same period last year ¥5.9 thousand, Indicator name SMB contract unit price / Value ¥47 thousand / Year on year against the same period last year ¥2.2 thousand, Indicator name Number of ENT contract groups / Value 264 Group / Year on year against the same period last year 23.4 Group, Indicator name Number of SMB contracted companies / Value 2,178 companies / Year on year against the same period last year 9.2 companies
Number of employeesNumber of Employees 1,662 People / Record date End of September 2026 / Hiring plan Hiring to continue in the MHS business, MWS business and Corporate division.
New initiativesIn the MWS business, organize low-margin projects and shift sales efforts toward high-LTV, high-margin projects., In the MWS business, promote strict cost control, eliminate unprofitable projects and improve the turnover rate., Revamp the upselling structure for ENT customers in the MHS business., Improve the efficiency of customer support using AI., Strengthen collaboration between the occupational physician cloud platform and IC Co.'s return-to-work business.
Items this document does not state (16)
Gross Profit MarginSelling, general and administrative expensesResults for the three months of the current quarterBreakdown of Factors Affecting the ChangeNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In the MHS business, new customer acquisition and upselling among ENT customers exceeded plan, and IC Co. also exceeded plan in both revenue and profit. In the MWS business, revenue increased on new project wins, but profit margins declined due to an increase in low-margin projects, a higher staff turnover rate and the impact of upfront investment projects.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation for the Third Quarter of the Fiscal Year Ending December 2026 | Mental Health Technologies Co.,Ltd. (9218) timely disclosure | Komori